Skip to content

Clinical trials

COVID-19 trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Status: Unknown status Country / region: China Clear all

202 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20181
20191
202051
202145
202249
202350
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status202

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China National Biotec Group Company Limited11
Livzon Pharmaceutical Group Inc.6
The Second Affiliated Hospital of Chongqing Medical University6
Tongji Hospital6
Huashan Hospital5
Ruijin Hospital5
Sinovac Life Sciences Co., Ltd.5
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology5
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.4
Beijing 302 Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19202
HIV Infections4
Bronchitis, Chronic3
Coronavirus Infections3
Infections3
Pneumonia3
Pulmonary Disease, Chronic Obstructive3
Cardiovascular Diseases2
Cytokine Release Syndrome2
Liver Diseases2

Trials

Showing 1 to 25 of 202. Each trial links to its page on Pharma Observatory.

102 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.